摘要:
The present invention relates to cyclin D1-derived peptides for use in the improved treatment of cancer in a patient, particularly in the form of a combination therapy using a vaccine. Other aspects relate to the use of the peptides or a combination thereof as a diagnostic tool.
摘要:
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 95 novel peptide sequences and their variants derived from HLA class I molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
摘要:
The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumor immune responses against gastric cancers (GC).
摘要:
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 95 novel peptide sequences and their variants derived from HLA class I molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
摘要:
The present invention relates to cyclin D1-derived peptides for use in the improved treatment of cancer in a patient, particularly in the form of a combination therapy using a vaccine. Other aspects relate to the use of the peptides or a combination thereof as a diagnostic tool.
摘要:
The present invention relates to the use of myeloid cell biomarkers for the differential diagnosis, prognosis, and monitoring of renal cell carcinoma (RCC) or colorectal cancer (CRC). The present invention furthermore relates to monitoring the effect of a treatment against renal cell carcinoma (RCC) or colorectal cancer (CRC), and establishing a prognosis of the outcome of the treatment of renal cell carcinoma (RCC) or colorectal cancer (CRC). The present invention furthermore relates to panels of cellular biomarkers for use in the above methods, in particular multicolor panels for measuring said biomarkers.
摘要:
A method of facilitating the dispensing of foreign currency from a foreign ATM to a user traveling in a foreign country wherein a system provider establishes a system home account and system foreign accounts each funded by deposit of the corresponding local currencies by users of the system.
摘要:
A method of facilitating the dispensing of foreign currency from a foreign ATM to a user traveling in a foreign country wherein a system provider establishes a system home account and system foreign accounts each funded by deposit of the corresponding local currencies by users of the system.
摘要:
A device and method for providing medical information to patients admitted in health care facilities such as hospitals, comprising a container with medical information relating to a medical condition provided on a display panel thereof, wherein the container can be used to store and transport a patient's personal items, wherein the container and medical information thereon is provided to the patient upon admission to the health care facility, the patient is educated regarding the information during the course of the patient's stay, and the patient is encouraged to take the container upon discharge from the facility.
摘要:
An exemplary database management device includes a database storage memory for storing database information. A user access memory at least temporarily stores information to be included in the database. At least a portion of the user access memory is configured to operate as a database manager that allows a user to indicate an intended change to the database information. The database manager places the intended change into the user access memory and determines whether the intended change complies with a criterion responsive to the user attempting to implement the intended change. The database manager makes the intended change to the database information in the database storage memory if the intended change complies with the criterion. The database manager provides an indication that the intended change will not be made to the database and the database storage memory if the intended change does not comply with the criterion.